Advertisement
Screener

Moleculin Biotech, Inc. (MBRX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Moleculin Biotech, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Moleculin Biotech, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $22.73M went out.
  • Fiscal year ended 2025-12-31: from investing, $0.00 came in.
  • Fiscal year ended 2025-12-31: from financing, $27.28M came in.
  • Fiscal year ended 2025-12-31: change in cash, $4.60M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$22.73M$0.00-$8.00K$27.29M*$4.60M
2024-12-31-$23.86M-$13.00K-$26.00K$4.66M*-$19.27M
2023-12-31-$23.59M-$124.00K-$25.00K$4.17M*-$19.59M
2022-12-31-$27.64M-$67.00K-$23.00K$0.00-$27.76M
2021-12-31-$18.95M-$19.00K-$23.00K$74.68M$55.73M
2020-12-31-$17.77M-$374.00K-$17.00K$22.56M$4.44M
2019-12-31-$17.20M-$51.00K$0.00$19.29M$1.56M*$3.60M
2018-12-31-$12.20M-$417.00K$5.00K$12.04M*-$580.00K
2017-12-31-$7.32M-$28.00K$0.00$10.06M*$2.71M
2016-12-31-$3.77M-$121.00K$8.87M*$4.98M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$6.66M*$0.00*$3.61M*
2026-03-31-$6.11M$0.00$7.61M*$1.44M
2025-12-31-$5.37M*$0.00*-$8.00K*$7.50M*
2025-09-30-$7.22M*$0.00*$0.00*$6.38M*
2025-06-30-$5.58M*$0.00*$5.42M*
2025-03-31-$4.56M$0.00$8.00M*$3.44M
2024-12-31-$5.08M*$0.00*$0.00*
2024-09-30-$6.11M*$0.00*-$1.00K*$4.66M*
2024-06-30-$5.95M*-$13.00K*$0.00*
2024-03-31-$6.72M$0.00$0.00-$6.73M
2023-12-31-$4.90M*-$81.00K*$0.00*$3.96M*
2023-09-30-$7.55M*-$28.00K*-$4.00K*$0.00*
2023-06-30-$5.13M*-$15.00K*$70.00K*
2023-03-31-$6.02M$0.00$141.00K-$5.88M
2022-12-31-$7.26M*$0.00*$0.00*$0.00*
2022-09-30-$7.58M*$0.00*-$11.00K*$0.00*
2022-06-30-$8.00M*-$61.00K*$0.00*
2022-03-31-$4.80M-$6.00K$0.00-$4.80M
2021-12-31-$4.26M*-$19.00K*$1.00K*-$1.00K*
2021-09-30-$4.29M*$0.00*-$24.00K*$0.00*
2021-06-30-$6.78M*$0.00*$0.00*
2021-03-31-$3.62M$0.00$74.69M$71.12M
2020-12-31-$3.12M*-$14.00K*$0.00*$5.48M*
2020-09-30-$5.37M*-$340.00K*$1.78M*
2020-06-30-$4.93M*-$18.00K*$10.01M*
2020-03-31-$4.34M-$2.00K$5.29M$914.00K
2019-12-31-$4.68M*-$9.00K*$0.00*$0.00*
2019-09-30-$3.33M*-$8.00K*$52.00K*
2019-06-30-$5.35M*-$19.00K*$13.72M*$1.56M*
2019-03-31-$3.85M-$15.00K$5.52M$1.65M
2018-12-31-$3.11M*-$114.00K*$5.00K*$1.76M*-$1.47M*
2018-09-30-$2.82M*-$295.00K*$0.00*-$3.12M*
2018-06-30-$3.47M*$0.00*$0.00*$2.07M*-$1.39M*
2018-03-31-$2.81M-$8.00K$0.00$8.21M*$5.40M
2017-12-31-$2.39M*-$16.00K*$1.38M*-$1.02M*
2017-09-30-$1.61M*-$8.00K*$1.08M*-$536.00K*
2017-06-30-$1.93M*-$4.00K*$2.33M*$391.00K*
2017-03-31-$1.39M$0.00$5.26M*$3.87M
2016-12-31-$1.17M*-$11.00K*-$1.18M*
2016-09-30-$951.65K*-$109.79K*-$1.06M*
2016-06-30-$1.35M*$30.00K*$8.31M*$6.99M*
2016-03-31-$290.00K-$30.00K$386.50K$232.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
MetaVia Inc. (MTVA)United States$0.011B-0.65
KALA BIO, Inc. (KALA)United States$0.011B-3.33
Theriva Biologics, Inc. (TOVX)United States$0.011B
Dare Bioscience, Inc. (DARE)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92